腎性貧血(Renal Anemia):治療薬市場動向2015(市場規模、APIメーカー動向、上市品、フェーズ3治験)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2015400)
◆英語タイトル:Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2015400
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:75以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,000 ⇒換算¥224,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥672,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[腎性貧血(Renal Anemia):治療薬市場動向2015(市場規模、APIメーカー動向、上市品、フェーズ3治験)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s, “Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Renal Anemia. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Renal Anemia. The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Renal Anemia. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturersacross the globe coveringDrug Master FilingsofUS, Europe and API Manufacturers in Asia specifically China and India. The researchanalysis also presents the global sales forecasts data till 2016.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market therapeutics scenario for Renal Anemia.
• A review of the marketed products under prescription for Renal Anemia, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Renal Anemia with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Renal Anemia drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Renal Anemia drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Renal Anemia drugs.
• Coverage of Renal Anemia Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2012-2016.

*** レポート目次(コンテンツ)***

Table of Contents
Indication Overview
Marketed Drugs
Marketed Details of Drugs by Application Type
Marketed Details of Drugs (NDA) by Marketing Status
Marketed Details of Drugs by Patent Expiration Timeline
Active Pharmaceutical Ingredient (API) Manufacturers Assessment
API Manufacturers by United States Drug Master File (US DMF) Status
API Manufacturers by US DMF Status (Drug Specific)
API Manufacturers in Europe by Country
API Manufacturers in India by State
API Manufacturers in China by Province
Marketed Details of Approved Drugs by Geography
Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
API Manufacturers by US DMF Status (Drug Specific)
Drugs Market Data and Forecasted Sales Figure (2012-2016)
Marketed Drugs for Renal Anemia
Drug Name
Drug Description
Global Active Pharmaceutical Manufacturers for Drug
Approval Status of Drug
Patent and Exclusivity Details for Drug
Company Profile and Financials
Phase III Drugs for Renal Anemia
United States Drug Master File (DMF)
Discontinued Drugs for Renal Anemia
Appendix
Methodology
Contact Us
Disclaimer

List of Tables
Renal Anemia Therapeutic Market, US, Marketed Drugs by Application Type, 2015
Renal Anemia Therapeutic Market, US, Marketed Drugs by Marketing Status, 2015
Renal Anemia Therapeutic Market, US, (Year), 2015
Renal Anemia Marketed Drugs, API Manufacturers by US DMF Status, 2015
Renal Anemia Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Renal Anemia Drugs, API Manufacturers, Europe by Country, 2015
Renal Anemia Drugs, API Manufacturers, India by State, 2015
Renal Anemia Drugs, API Manufacturers, China by Province, 2015
Renal Anemia Drugs, API Manufacturers by Geography 2015
Renal Anemia Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2015
Renal Anemia Therapeutic Market, Global Sales 2012-2016 (in million USD)
API Manufacturers for Drug, 2015
Phase III Drugs for Renal Anemia, 2015
Discontinued Drugs for Renal Anemia, 2015


List of Figures
Renal Anemia Therapeutic Market, US, Marketed Drugs by Application Type (%), 2015
Renal Anemia Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2015
Renal Anemia Therapeutic Market, US, (Year), 2015
Renal Anemia Marketed Drugs, API Manufacturers by US DMF Status (%), 2015
Renal Anemia Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Renal Anemia Drugs, API Manufacturers, Europe by Country, 2015
Renal Anemia Drugs, API Manufacturers, India by State, 2015
Renal Anemia Drugs, API Manufacturers, China by Province, 2015
Renal Anemia Drugs, API Manufacturers by Geography 2015
Renal Anemia Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2015
Renal Anemia Therapeutic Market, Global Sales 2012-2016 (in million USD)
Drug, Patent/Exclusivity Expiry (Year), 2015


*** レポートのキーワード ***

腎性貧血(Renal Anemia)、医薬品、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 砂濾過装置の世界及び中国市場 2018年
    The 'Global and Chinese Sand Separator Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Sand Separator industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sand Separator manufac …
  • 世界の3-メチルブチルクロロアセテート市場2017
    3-Methylbutyl Chloroacetate Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United St …
  • 世界及び中国の回転成形樹脂市場2017
    The 'Global and Chinese Rotational molding resins Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Rotational molding resins industry with a focus on the Chinese market. The report provides key statistics on the market status of the …
  • 艦砲の世界市場
    Naval Artillery Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, German …
  • 世界及び中国のプラスチック3D印刷材料市場2017
    The 'Global and Chinese Plastics 3D Printing Materials Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Plastics 3D Printing Materials industry with a focus on the Chinese market. The report provides key statistics on the market stat …
  • Milano Assicurazioni S.p.A. (MI) – 企業概要
    WMI's 'Milano Assicurazioni S.p.A. (MI) - Company Capsule' is a crucial resource for industry executives and anyone looking to access key information about 'Milano Assicurazioni S.p.A.'. WMI's 'Milano Assicurazioni S.p.A. (MI) - Company Capsule' report utilizes a wide range of primary and secondary …
  • Gulf Hotels (Oman) Company Limited SAOG (GHOS):企業概要及び分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Gulf Hotels (Oman) Company Limited SAOG" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Wor …
  • 次世代パッケージングの世界市場:産業分析・機会分析
    Report Synopsis FMI study offers a 10-year forecast for the global next generation packaging market between 2015 and 2025. The market is expected to expand at a CAGR of 6.01% during the projected period. The study demonstrates the market dynamics and trends which are anticipated to influence the cur …
  • オーストラリアの関節鏡検査処置動向(~2021)
    Australia Arthroscopy Procedures Outlook to 2021 Summary GlobalData’s new report, "Australia Arthroscopy Procedures Outlook to 2021", provides key procedures data on the Australia Arthroscopy Procedures. The report provides procedure volumes within market segments - Shoulder Arthroscopy Procedures, …
  • Genextra S.p.a.:製薬企業の製品開発パイプライン2014
    Genextra S.p.a. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Genextra S.p.a. - Product Pipeline Review - 2014’, provides an overview of the Genextra S.p.a.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2015400 )"腎性貧血(Renal Anemia):治療薬市場動向2015(市場規模、APIメーカー動向、上市品、フェーズ3治験)" (英文:Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。